A new documentary leaves out some aspects of the gene-editing technology
2020-05-09
The edited T cells caused no serious side effects in the trial’s 3 participants.
2020-05-08
The idea of a borderless world can suggest vulnerability—or the benefits of freely sharing ideas and, ultimately, creating and sustaining globe-spanning cell therapy supply chains.
2020-05-07
If you want to "clean up" in the recombinant protein business, you might want to start by sweeping away process-related impurities, specifically, host cell proteins (HCPs). Undesirable HCPs are generated by host cells along with desirable biotherapeutic proteins, increasing metabo…
2020-05-06
Scientists at the University of Texas (UT) Southwestern Medical Center used CRISPR-based screening to help identify a mechanism by which cancer cells can regulate the production of a protein that suppresses immune system responses against the tumor. The team's combined studies in …
2020-04-29
Researchers have identified specific types of cells that appear to be the targets of the SARS-Cov-2 coronavirus that is causing the Covid-19 pandemic.
2020-04-28
As a means of transfection, conventional electroporation has been limited by its toxic effects. A less toxic electroporation option has been developed by Lonza. This option, Nucleofector, encompasses instrumentation, solution/supplement kits, and optimized protocols. It can ad-dre…
2020-04-27
Brain cells have no difficulty accommodating normal tau protein. In fact, tau protein maintains structure and stability within neurons, and it helps the transport of nutrients from one part of the cell to another. But abnormal tau protein is an unwelcome guest. By dint of its aber…
2020-04-22
Scientists at the University of California-San Diego say they have moved one step closer to the ability to make heparin in cultured cells. Heparin is a potent anti-coagulant and the most prescribed drug in hospitals, yet cell-culture-based production of heparin is currently not po…
2020-04-21
TEL :
+86 153 6067 3248 (Int'l)
US Toll free:
855 777 3210
EU Toll free:
800 3272 9252
Korea Toll free:
001 800 3272 9252 (Telecom)
002 800 3272 9252 (Dacom )
008 800 3272 9252 (Onse)
Products Gene Editing Services
Phone
Contact
